[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344488-105":59,"doc-detail-344488-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","editorial-unlocking-cancers-secrets-overcoming-drug-resistance-in-cancer-stem-cells","Editorial: Unlocking cancer’s secrets - overcoming drug resistance in cancer stem cells","","Editorial introduces the Research Topic “Unlocking cancer’s secrets: overcoming drug resistance in cancer stem cells,” addressing therapeutic resistance as a major obstacle in modern oncology. It links tumor recurrence, metastasis, and treatment failure to dynamic cancer cell states driven by stemness, plasticity, and adaptive responses, with cancer stem cells (CSCs) acting as central mediators. The editorial summarizes six contributions spanning reviews and original studies, highlighting roles of tumor microenvironment interactions, CSC and drug-tolerant persister plasticity, and predictive biomarker discovery to guide precision strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/editorial-unlocking-cancers-secrets-overcoming-drug-resistance-in-cancer-stem-cells/344488/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/editorial-unlocking-cancers-secrets-overcoming-drug-resistance-in-cancer-stem-cells/344488.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is drug resistance a central challenge in modern oncology according to the editorial?","Question",{"text":112,"@type":113},"Therapeutic resistance limits long-term survival by driving tumor recurrence, metastatic dissemination, and treatment failure across many cancers. The editorial emphasizes that resistance is not only genetic but also driven by dynamic cellular states.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do cancer stem cells contribute to therapeutic resistance and progression?",{"text":117,"@type":113},"CSCs sustain tumor heterogeneity and enable survival under lethal conditions. They are linked to self-renewal, pro-survival signaling, metabolic adaptability, DNA repair, and interactions with the tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the Research Topic intended to highlight and explore?",{"text":121,"@type":113},"It highlights emerging molecular and cellular mechanisms underlying CSC-associated resistance and examines innovative therapeutic strategies to overcome these barriers. It also emphasizes the influence of CSC–microenvironment interactions on treatment response and immune escape.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344488,1790193987,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":81,"preview_urls":144},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","OPEN ACCESS  \nEDITED AND REVIEWED BY  \nWagdy Mohamed Eldehna, Kafrelsheikh University, Egypt  \n*CORRESPONDENCE  \nStefano Martellucci,  \n [s.martellucci@unilink.it](s.martellucci@unilink.it)  \nRECEIVED 18 June 2026  \nACCEPTED 26 June 2026  \nPUBLISHED 15 July 2026  \nCITATION  \nMartellucci S (2026) Editorial: Unlocking cancer’s secrets: overcoming drug resistance in cancer stem cells.  \nFront. Pharmacol. 17:1913266 .  \ndoi: 10.3389/fphar.2026.1913266  \nCOPYRIGHT  \n© 2026 Martellucci. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTYPE Editorial  \nPUBLISHED 15 July 2026  \nDOI 10.3389/fphar.2026.1913266  \nEditorial: Unlocking cancer’s  \nsecrets: overcoming drug resistance in cancer stem cells  \nStefano Martellucci*  \nDepartment of Life Sciences, Health, and Health Professions, Link Campus University, Rome, Italy  \nKEYWORDS  \ncancer recurrence, cancer stem cells (CSC), CSC sensitization, CSC-mediated resistance, drug resistance, tumor microenvironment  \nEditorial on the Research Topic  \nUnlocking cancer’s secrets: overcoming drug resistance in cancer stem cells  \nDespite remarkable advances in cancer diagnosis and treatment, therapeutic resistance remains one of the greatest challenges in modern oncology (Holohan et al., 2013; Marine et al., 2020) . Tumor recurrence, metastatic dissemination, and treatment failure continue to limit long-term patient survival across a broad range of malignancies. Increasing evidence indicates that these phenomena are driven not only by genetic alterations but also by dynamic cellular states characterized by stemness, plasticity, and adaptive responses to therapeutic pressure (Batlle and Clevers, 2017; Meacham and Morrison, 2013) . Cancer stem cells (CSCs), together with other therapy-tolerant cell populations, have emerged as central mediators of these processes, sustaining tumor heterogeneity, promoting tumor evolution, and enabling survival under otherwise lethal conditions (Dean et al., 2005; Zhou et al., 2021) . CSCs are characterized by enhanced self-renewal capacity, activation of pro-survival signaling networks, metabolic adaptability, efficient DNA repair mechanisms, and dynamic interactions with the tumor microenvironment, all of which contribute to therapeutic resistance, tumor recurrence, and metastatic progression (Marine et al., 2020; Liu and Wang, 2024) .  \nThe Research Topic “Unlocking Cancer’s Secrets: Overcoming Drug Resistance in Cancer Stem Cells” was conceived to highlight emerging advances in our understanding of the molecular and cellular mechanisms underpinning CSC-associated resistance and to explore innovative therapeutic strategies to overcome these barriers. Beyond intrinsic cellular programs, interactions between CSCs and the tumor microenvironment critically influence treatment response, metastatic dissemination, and immune escape (Batlle and Clevers, 2017; Prager et al., 2019; Liu and Wang, 2024) . The six contributions collected in this Research Topic encompass diverse cancer types, experimental models, and methodological approaches, ranging from comprehensive reviews of CSC biology to original studies that identify biomarkers of treatment response and evaluate novel therapeutic agents targeting stemness-associated pathways.  \nA recurring theme across several contributions is the remarkable plasticity of resistant tumor cell populations. In their comprehensive review of liver cancer stem cells in hepatocellular carcinoma, Yadav et al. provide an extensive overview of CSC markers, signaling pathways, microenvironmental interactions, and mechanisms responsible for  \nFrontiers","cbCaip60nQs11LCS","https://ap.wps.com/l/cbCaip60nQs11LCS","pdf",1795820,"English","# Editorial on the Research Topic\n## Unlocking cancer’s secrets: overcoming drug resistance in cancer stem cells\n## Contributions and recurring themes\n### Plasticity and drug-tolerant persister cells\n### Predictive biomarkers and therapeutic decision-making","[{\"question\":\"Why is drug resistance a central challenge in modern oncology according to the editorial?\",\"answer\":\"Therapeutic resistance limits long-term survival by driving tumor recurrence, metastatic dissemination, and treatment failure across many cancers. The editorial emphasizes that resistance is not only genetic but also driven by dynamic cellular states.\"},{\"question\":\"How do cancer stem cells contribute to therapeutic resistance and progression?\",\"answer\":\"CSCs sustain tumor heterogeneity and enable survival under lethal conditions. They are linked to self-renewal, pro-survival signaling, metabolic adaptability, DNA repair, and interactions with the tumor microenvironment.\"},{\"question\":\"What is the Research Topic intended to highlight and explore?\",\"answer\":\"It highlights emerging molecular and cellular mechanisms underlying CSC-associated resistance and examines innovative therapeutic strategies to overcome these barriers. It also emphasizes the influence of CSC–microenvironment interactions on treatment response and immune escape.\"}]","Editorial: Unlocking cancer’s secrets - overcoming drug resistance in cancer stem cells | PDF",1790054030,[145,149,153],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4eccee3102706ae1531d255b4d037e62.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/022355da164ce28412b9a4e75953881a.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26bc520d017cb86e9a32180de9ce8da5.webp",981,1387]